Trial Summary
What is the purpose of this trial?This trial studies how well positron emission tomography/magnetic resonance imaging (PET/MRI) scan works in checking patients with stage IA1-IB3 cervical cancer that can be removed by surgery (resectable). PET/MRI scan may help doctors learn more about the spread of the disease.
Eligibility Criteria
This trial is for individuals with suspected early-stage cervical cancer (IA1-IB3) that can potentially be removed by surgery. Participants must not have tumors larger than 4 cm, should have no issues with undergoing MRI scans, and will be having their surgical procedure at MD Anderson.Inclusion Criteria
My cervical cancer is in the early stages and my tumor is not larger than 4 cm.
No contraindications to MRI
I am suspected to have cervical cancer.
+1 more
Participant Groups
The study is evaluating the effectiveness of PET/MRI scans using Gadobutrol and Fludeoxyglucose F-18 in assessing the spread of early-stage cervical cancer before surgery.
1Treatment groups
Experimental Treatment
Group I: Diagnostic (PET/MRI)Experimental Treatment4 Interventions
Patients receive fludeoxyglucose F-18 and gadobutrol IV over 1 minute and undergo PET/MRI over 90-120 minutes.
Find a Clinic Near You
Research Locations NearbySelect from list below to view details:
M D Anderson Cancer CenterHouston, TX
Loading ...
Who Is Running the Clinical Trial?
M.D. Anderson Cancer CenterLead Sponsor
National Cancer Institute (NCI)Collaborator